Despite price increases, Haleon's roster of products has largely kept cheaper private-label competition at bay, although the cost-of-living squeeze and competition among painkiller brands are allowing rivals to catch up. Demand in China has slowed after a strong rebound last year post-COVID-19 - a trend that has been echoed by U.S. rival Kenvue, which forecast full-year profit below analysts' expectations earlier this month. In the first quarter of 2023, Haleon's organic revenue grew by 9.9%, on a 33% jump in sales for its respiratory health products in the cold and flu season.
ST. LOUIS Expanding its product offerings beyond its long-running line of chewable tablets, antacid manufacturer Tums introduced a new sternly worded note Tuesday that reportedly works by reminding consumers they know better than to eat that stuff in the first place. “The best method of heartburn relief remains having…
A deep understanding of human biology, tapping on trusted science and key partnerships with researchers, start-ups and suppliers are key in achieving new breakthroughs in nutraceuticals innovation, Haleon’s chief of R&D told NutraIngredients-Asia in an exclusive interview.
Warren, New Jersey-based Haleon is recalling eight lots of Robitussin branded Honey CF Max Day Adult and Honey CF Max Nighttime Adult citing microbial contamination, according to the U.